Epigenetics Core
Epigenetics Core
批准号:
7540231
负责人:
MICHAEL A TEITELL
金额:
$10.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2013-07-31
关键词:
AcademiaAdoptedAdoptionAreaBioinformaticsBiological AssayCell CountCellsChromatinCommunitiesConditionCore FacilityCytogeneticsDNADNA MethylationDataData CollectionDetectionEpigenetic ProcessGene ExpressionGene TargetingGenesGenomeGenomicsGrowthHistone H3HistonesHuman ResourcesHybridization ArrayJonsson Comprehensive Cancer Center of University of California Los AngelesLettersLinkMeasurementMethodsMethylationModificationMolecular ProfilingPan GenusPatternPolymerase Chain ReactionProceduresProcessProtocols documentationPublishingRoleSamplingScienceServicesStandards of Weights and MeasuresTechniquesTechnologyTrainingTranscription Initiation SiteUC01UC06ValidationWA01 cell lineWA09 Cell Lineadvanced systemanalytical toolbisulfitechromatin immunoprecipitationcomparativedata acquisitiongenome sequencinghuman embryonic stem cellinterestprogramspromotertechnology developmenttool development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Epigenetics Core (Core C) provides genome-wide DMA methylation, histone modification, and chromatin
immunoprecipitation (ChIP) services, along with targeted gene region analysis and validation, to support the
Program Projects. The Epigenetics Core provides direct linkage of services to the Administrative Core A,
hESC Core B, Computational/Bioinformatics Core D and also to essential existing UCLA cores, including the
Gene Expression Core Facility (S Nelson). The Epigenetics Core is strongly supported by Agilent
Technologies (for array platforms, probe technologies, and analytical tool development and adoption) and by
key consultants that support Core services, including C Plass and T Huang (DMA methylation), M Grunstein
and S Kurdistani (histone modification), and H Cedar (ChIP). Core C will provide genome-wide or targeted
detection and validation for altered patterns of DNA methylation in hESCs and derivative differentiated cells
from the hESC Core B and from Program Projects 1-3. Core C provides ChIP procedures, probe
manufacture, array hybridizations, data collection, and analysis through transfer of data to Computational/
Bioinformatics Core D. The Epigenetics Core will distribute information and protocols and help train
personnel (as needed) in each of the Program Projects and Cores and will have a limited but important role
in technology development, focusing mainly on reducing cell number inputs for array ChlP-chip technologies
with Core users and assessing/incorporating advances in epigenetic modification detection as they become
available through the general scientific community and in conjunction with Agilent Technologies. Access to
the Solexa 1G high throughput sequencing system for advanced ChlP-chip analysis is through the UCLA
Gene Expression Core Facility (S Nelson). As an essential comparative service to the Program Project and
to the hESC community as a whole, Epigenetics Core C will provide baseline measurements of global DNA
methylation, pan-acetylated histone H3 and H4, and di- and tri-methylated histones, epigenetic markings that
reflect active or silenced gene expression, for optimally grown low-passage federally-approved hESC lines
UC 01 (HSF-1), UC 06 (HSF-6), WA01 (H1), and Wa09 (H9) for comparative analysis. Expression profiling
for these 4 federally-approved lines (already published or to be performed in the existing UCLA Gene
Expression Core Facility) will provide a link between epigenetic signatures and effects on hESC gene
expression. This information will be made available in a publicly accessible portion of the Program Project
Website, with data entry and manipulation password protected.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetics Core
-
批准号:8379989
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2012
-
负责人:MICHAEL A TEITELL
-
依托单位:
A Fourth Outcome: DNA Damage and the Differentiation of B Cells
-
批准号:8447385
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2011
-
负责人:MICHAEL A TEITELL
-
依托单位:
A Fourth Outcome: DNA Damage and the Differentiation of B Cells
-
批准号:8050719
-
项目类别:
-
资助金额:$31.49万
-
财政年份:2011
-
负责人:MICHAEL A TEITELL
-
依托单位:
A Fourth Outcome: DNA Damage and the Differentiation of B Cells
-
批准号:8633428
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2011
-
负责人:MICHAEL A TEITELL
-
依托单位:
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
-
批准号:6880146
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2004
-
负责人:MICHAEL A TEITELL
-
依托单位:
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
-
批准号:7213270
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2004
-
负责人:MICHAEL A TEITELL
-
依托单位:
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
-
批准号:6768423
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2004
-
负责人:MICHAEL A TEITELL
-
依托单位:
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
-
批准号:7022309
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2004
-
负责人:MICHAEL A TEITELL
-
依托单位:
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
-
批准号:7367797
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2004
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA
-
批准号:6507940
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA
-
批准号:6772509
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA
-
批准号:7050967
-
项目类别:
-
资助金额:$0.88万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
CRTC2 in Cellular Development, Function, and Neoplasia
-
批准号:8130653
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
CRTC2 in Cellular Development, Function, and Neoplasia
-
批准号:8462450
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA
-
批准号:6914836
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA
-
批准号:7075410
-
项目类别:
-
资助金额:$26.16万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA
-
批准号:6641279
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
CRTC2 in Cellular Development, Function, and Neoplasia
-
批准号:8677727
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 Oncogene in B Lymphocyte Development and Neoplasia
-
批准号:7486806
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
TCL1 Oncogene in B Lymphocyte Development and Neoplasia
-
批准号:7901615
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2002
-
负责人:MICHAEL A TEITELL
-
依托单位:
海外基金